Abstract:The solid tumors are characterized with oxidative stress and metabolic reprogramming, which has been independently used for targeted tumor monotherapy. However, the potential of targeting metabolism-redox circuit in tumor therapy has long been neglected. Herein, we report a hybrid nanocarrier for concurrent targeting of glycolysis and redox balance in the current work. The nanocarriers are made of pH- and ATP-responsive zeolitic imidazolate framework (ZIF-8) as the porous core that was further coated with poloxamer 407 as the steric stabilizer. Two active cargos, glucose oxidase (GOx) and 3-bromopyruvate (3-BrPA) were co-loaded in the core of nanocarrier. GOx is well-known for its ability of producing hydrogen peroxide at the expense of glucose and oxygen. 3-BrPA can reduce oxygen and glucose consumption through glycolysis, which sensitized cancer cells to GOx-induced apoptosis. At the cellular level, the hybrid nanocarrier significantly impaired the redox balance in the liver hepatocellular carcinoma cell line (HepG2), as evidenced by the depletion of glutathione and boost of reactive oxygen species. The potency of hybrid nanocarrier in terms of suppressing HepG2 cell energy metabolism was proven by the exhaustion of ATP. As a consequence, cell viability was greatly reduced. The in vivo efficacy of hybrid nanocarriers was demonstrated in HepG2 tumor-bearing mice. The current work presents an approach of targeting metabolism-redox circuit for tumor treatment, which may enrich the available anti-tumor strategies. Statement of Significance Metabolic alterations and elevated reactive oxygen species (ROS) are two characteristics of cancer. The metabolic patterns of cancer cells are elaborately reprogrammed to enable the rapid propagation of cancer cells. However, the potential of targeting the metabolism-redox circuit in anti-tumor therapy has long been neglected. As a proof-of-concept, we report an engineered stimuli-responsive nanomedicine that can eradicate cancer cells via cooperative glycolysis inhibition and redox impairment. The current work presents an approach of targeting the metabolism-redox circuit for tumor treatment, which may enrich the available anti-tumor strategies.

Roles of Ion Fluxes, Metabolism, and Redox Balance in Cancer Therapy

Redox regulation and its emerging roles in cancer treatment

Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy

Modulation of redox homeostasis: A strategy to overcome cancer drug resistance

Targeting the Redox Landscape in Cancer Therapy

Metabolic Regulation of Redox Balance in Cancer

Modulation of redox signal transduction pathways in the treatment of cancer

Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies

Modulating Intracellular Oxidative Stress Via Engineered Nanotherapeutics

The double-edged roles of ROS in cancer prevention and therapy

Novel therapeutic strategy for cancer and autoimmune conditions: Modulating cell metabolism and redox capacity

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

The Cancer Antioxidant Regulation System in Therapeutic Resistance

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Emerging strategies to target cancer metabolism and improve radiation therapy outcomes

Stimuli-responsive cancer nanomedicines inhibit glycolysis and impair redox homeostasis

Natural compounds targeting cellular redox homeostasis in malignancies

Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy

Metabolism-Regulating Nanozyme System for Advanced Nanocatalytic Cancer Therapy

Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy